The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Clincal Research on Aerosolizing Inhalation Recombinated Antituberculosis Medicine in the Treatment of Pulmonary Tuberculosis Patients with Sputum Smear Positive
Author(s): 
Pages: 21,24
Year: Issue:  1
Journal: HAERBIN MEDICAL JOURNAL

Keyword:  雾化吸入肺结核痰涂阳;
Abstract: 目的 观察和评价雾化吸入抗结核药治疗开放型肺结核疗效.方法 将我科近两年收治的确诊为双或单肺浸润型结核痰涂阳性者约43人,随机分成观察组和对照组.观察组21例除常规给予化疗药物外还给予应用氧驱动的雾化吸人异烟肼注射液0.1g,链霉素0.25g加入生理盐水20ml,氧流量为5L/m33,每天2次,每次持续15~20分钟,共用20天.对照组只应用一般的抗结核药.结果 观察组治疗1个月、2个月和3个月的痰涂阴转率,咳嗽症状缓解和消失率及肺部病灶吸收好转速度均明显优于对照组.结论 雾化吸入抗结核药治疗开放型肺结核疗效显著.
Related Articles
No related articles found